Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Saturation genome editing of BARD1 resolves VUS and provides insight into BRCA1-BARD1 tumor suppression. | medRxiv | 2025 | 41282735 | PubTator, text mining | PubMed |
| Key genes and associated mechanisms of PCOS and EC comorbidity: A bioinformatics analysis. | Medicine (Baltimore) | 2025 | 41239694 | PubTator, text mining | PubMed |
| Dysregulated BARD1 Contributes to Paclitaxel Resistance in Ovarian Cancer via Up-regulating CYP2C8. | Folia Biol (Praha) | 2025 | 41165155 | PubTator, text mining | PubMed |
| Recontact and follow-up for individuals with germline pathogenic variants in hereditary breast and ovarian cancer susceptibility genes: a UK Cancer Genetics Group consensus meeting. | J Med Genet | 2025 | 41159931 | PubTator, text mining | PubMed |
| Homologous Recombination in Thyroid Tumor Samples. | Int J Mol Sci | 2025 | 41096981 | PubTator, text mining | PubMed |
| Investigation of DNA Damage Response Genes Validates the Role of DNA Repair in Pediatric Cancer Risk and Identifies SMARCAL1 as a Novel Osteosarcoma Predisposition Gene. | J Clin Oncol | 2025 | 41066719 | PubTator, text mining | PubMed |
| DNA damage-dependent mechanisms of ionizing radiation-induced cellular senescence. | PeerJ | 2025 | 41048400 | PubTator, text mining | PubMed |
| Contribution of BARD1 gene to male breast cancer- report of a family with different types of cancer. | Curr Probl Cancer | 2025 | 41045837 | PubTator, text mining | PubMed |
| Meta-analysis of exome-wide gene burden analysis of breast cancer susceptibility genes. | NPJ Breast Cancer | 2025 | 41044259 | PubTator, text mining | PubMed |
| Germline homologous recombination repair (gHRR) variants in bladder cancer: Preliminary evidence and clinical implications. | BJUI Compass | 2025 | 41018918 | PubTator, text mining | PubMed |
| BARD1: A Friend or Foe in Pancreatic Ductal Adenocarcinoma? | Int J Mol Sci | 2025 | 41009605 | PubTator, text mining | PubMed |
| EXO1 as a therapeutic target for Fanconi Anaemia, ZRSR2 and BRCA1-A complex deficient cancers. | Nat Commun | 2025 | 41006228 | PubTator, text mining | PubMed |
| Prevalence of MUTYH Monoallelic Variants in Patients With Hereditary Cancer Using Multigene Panel Testing. | Cancer Med | 2025 | 41001951 | PubTator, text mining | PubMed |
| Damage-induced phosphorylation of BRC-1/BRD-1 in meiosis preserves germline integrity. | Nucleic Acids Res | 2025 | 40990247 | PubTator, text mining | PubMed |
Complete remission with olaparib in BRIP1-mutated metastatic high-grade pleomorphic sarcoma: case study and literature review - an example of a genomic profiling-based tumor treatment, in a cancer type with high unmet clinical need. | Acta Oncol | 2025 | 40988318 | PubTator, text mining | PubMed |
| Association of TRDMT1 Gene Polymorphisms With Neuroblastoma Susceptibility: Insights From a Case-Control Study. | J Cell Mol Med | 2025 | 40984038 | PubTator, text mining | PubMed |
| Author Correction: Mechanism of BRCA1-BARD1 function in DNA end resection and DNA protection. | Nature | 2025 | 40983763 | PubTator, text mining | PubMed |
| PARP inhibitors in gastric cancer: unlocking precision oncology. | Oncologist | 2025 | 40973024 | PubTator, text mining | PubMed |
| Post-translational modification of H2B C-terminal helix regulates nucleosome interactions and chromatin signaling. | Nucleic Acids Res | 2025 | 40966523 | PubTator, text mining | PubMed |
| Cancer histone mutations impact protein binding and DNA repair with possible links to genomic instability. | Nucleic Acids Res | 2025 | 40966522 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=6